Aiosyn Newsletter - October 2024
The first solution for kidney biopsy analysis available on Sectra Amplifier Marketplace!
Huge advancement for renal pathology! NephroPath GlomeruCount, a glomerular quantification algorithm, is the first solution for kidney biopsies featured on Sectra Amplifier Marketplace. GlomeruCount is part of the NephroPath platform, Aiosyn’s suite of AI-powered computational pathology algorithms designed for precise kidney lesion quantification. NephroPath’s AI quantification tools offer faster, more reproducible, and more detailed scoring of renal pathology biomarkers compared to traditional assessments.
"As the first AI solution for kidney biopsy analysis on the Sectra platform, it paves the way for more deep-learning algorithms that provide assessments of renal histological biomarkers. Our goal with NephroPath's technology is to provide quantitative kidney tissue assessments and drive advancements in kidney disease research and diagnosis."
- Thomas de Bel, NephroPath Product Lead and AI Engineer
Thank you for joining us at the European Congress of Pathology and the 2024 Banff-PITOR Joint Meeting
September was an exciting month as we had the opportunity to connect with pathology experts and industry leaders at two events in the beautiful cities of Florence and Paris. A big thank you to the event organizers, attendees, and fellow exhibitors. Your efforts are what help drive the growth and progress of our industry!
AI Act and Digital Pathology: Navigating New Regulations
How will the AI Act shape the future of digital pathology solutions that rely on AI? In our latest blog article, we explore the potential consequences and opportunities this legislation brings to the field.